Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium

Ola Landgren, Nicole Gormley, Danielle Turley, Roger G. Owen, Andy Rawstron, Bruno Paiva, David Barnett, Maria Arroz, Paul Wallace, Brian Durie, Constance Yuan, Ahmet Dogan, Maryalice Stetler-Stevenson, Gerald E. Marti

Research output: Contribution to journalArticle

44 Scopus citations
Original languageEnglish (US)
Pages (from-to)1159-1160
Number of pages2
JournalAmerican Journal of Hematology
Volume89
Issue number12
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Landgren, O., Gormley, N., Turley, D., Owen, R. G., Rawstron, A., Paiva, B., Barnett, D., Arroz, M., Wallace, P., Durie, B., Yuan, C., Dogan, A., Stetler-Stevenson, M., & Marti, G. E. (2014). Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium. American Journal of Hematology, 89(12), 1159-1160. https://doi.org/10.1002/ajh.23831